Results 11 to 20 of about 6,881 (266)
Genetic evaluation of juvenile xanthogranuloma: genomic abnormalities are uncommon in solitary lesions, advanced cases may show more complexity [PDF]
Modern Pathology, 2017 Yuri Fedoriw +2 more
exaly +3 more sources
BMC Pediatrics, 2021 Background Systemic juvenile xanthogranuloma is a very rare disease typically presents as skin lesions with yellow papules or nodules and is sometimes fatal.
Yohji Uehara +16 more
doaj +2 more sources
Dermoscopy in the diagnosis of juvenile xanthogranuloma [PDF]
Anais Brasileiros de Dermatologia, 2018 : Juvenile xanthogranuloma is the most common form of non-Langerhans cell histiocytosis. It manifests clinically as a red-yellow papule, usually showing spontaneous remission. The diagnosis is based on clinical and histological findings.
Thaís Erance de Oliveira +2 more
doaj +2 more sources
Xanthogranuloma in Adolescence [PDF]
Archives of Plastic Surgery, 2012 Xanthogranuloma is a benign, self-limiting disease caused by proliferation of cutaneous histiocytes. It is predominantly a disease of infancy or early childhood. Lesions generally develop on the head, neck, and upper extremities and present in various sizes and numbers.
Seong Oh Park +3 more
openalex +7 more sources
Journal of Cutaneous and Aesthetic Surgery, 2012 Necrobiotic xanthogranuloma is a rare, chronic, progressive granulomatous disorder which manifests as yellowish plaques and nodules, most commonly in the periorbital region. The exact aetiology is not known. It is commonly associated with monoclonal gammopathy. Various treatment modalities used include chemotherapy, intralesional and systemic steroids,
Banavasi Shanmukha Girisha +3 more
+8 more sources
NTRK expression is common in xanthogranuloma and is associated with the solitary variant
Journal of cutaneous pathology, 2023 Previously identified mutually‐exclusive driver genes in juvenile xanthogranuloma (JXG) and adult xanthogranuloma (AXG) include mutations in MAP kinase pathway genes such as MAP2K1, BRAF, ARAF, KRAS, NRAS, PIK3CD as well as fusions in BRAF and ALK, with ...
B. Umphress +6 more
semanticscholar +1 more source
Systemic therapy of necrobiotic xanthogranuloma: a systematic review
Orphanet Journal of Rare Diseases, 2022 Background Even though a plethora of systemic therapies have been proposed for necrobiotic xanthogranuloma (NXG), there is no systematic review on this topic in literature.
Lisa Steinhelfer +6 more
semanticscholar +1 more source
Journal of Personalized Medicine, 2022 Xanthogranuloma of the sellar region is a rare chronic inflammatory lesion resulting from secondary hemorrhage, inflammation, infarction, and necrosis of an existing Rathke’s cleft cyst, craniopharyngioma, or pituitary adenoma.
Vera Lozovanu +6 more
semanticscholar +1 more source
Solitary juvenile xanthogranuloma of temporal bone: a case report
BMC Pediatrics, 2022 Background Juvenile xanthogranuloma (JXG) is a kind of non-Langerhans cell histiocytosis, usually with skin lesions as the main manifestation. It rarely occurs in other tissues or organs and even more rarely is it found in the skull.
Shu-ni Wang, Ji Lu
semanticscholar +1 more source
Neuroimaging in Pediatric Patients with Juvenile Xanthogranuloma of the CNS
American Journal of Neuroradiology, 2022 BACKGROUND AND PURPOSE: Juvenile xanthogranuloma is a rare clonal, myeloid, neoplastic disorder. Typically, juvenile xanthogranuloma is a self-limited disorder of infancy, often presenting as a solitary red-brown or yellow skin papule/nodule.
B. Serrallach +11 more
semanticscholar +1 more source